Alex Janin is a Reporter at The Wall Street Journal. He focuses on health and wellness, covering topics such as nutrition, alternative medicine, and the impact of the coronavirus, alongside data and drug-related issues. Alex's work has been featured in The Wall Street Journal, Yahoo Finance, The Epoch Times, and LiveMint.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Alex Janin's articles predominantly focus on health-related topics, particularly those related to aging and exercise. His work often cites data and includes seasonal content. When reaching out to Alex, consider providing access to credible data or studies that support your pitch.
Given the thematic coverage of his articles, experts in gerontology, exercise physiology, public health or healthcare professionals with knowledge of trends related to aging and exercise may find success in pitching story ideas. Keep in mind that his geographic focus is national (United Kingdom).
This information evolves through artificial intelligence and human feedback. Improve this profile .
Injuries, colds, restless nights and alcohol can hit harder when we get into midlife.
By: Alex Janin
Injuries, colds, restless nights and alcohol can hit harder when we get into midlife.
Midday brushing can help clear away plaque — just don't floss at your desk. Let's face it, you're online right now, looking for updates and analysis.
The recent research on fasting isn’t as promising as scientists had once hoped.
The recent research on fasting isn't as promising as scientists had once hoped. Intermittent fasting probably isn't the health hack you hoped it would be.
By: Alex Janin, Julie Jargon, Sarah Blesener
A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic.
A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic.
A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic.
By: Alex Janin, Amy Dockser Marcus, Shane Shifflett
Harvard geneticist David Sinclair aims to develop treatments for aging, but his companies have struggled to deliver.
By: Alex Janin, Amy Dockser Marcus, Shane Shifflett
Harvard geneticist David Sinclair aims to develop treatments for aging, but his companies have struggled to deliver.
(833) 317-6278 
